BioMark Diagnostics Inc
OTC:BMKDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioMark Diagnostics Inc
OTC:BMKDF
|
CA |
|
Gale Pacific Ltd
ASX:GAP
|
AU |
|
F
|
Finansia X PCL
SET:FSX
|
TH |
|
C
|
Cadence Design Systems Inc
F:CDS
|
US |
|
Quantum Battery Metals Corp
F:23B
|
CA |
|
Light Science Technologies Holdings PLC
F:9FD
|
UK |
|
Roots Corp
TSX:ROOT
|
CA |
|
Visium Technologies Inc
OTC:VISM
|
US |
|
B
|
Bualuang Office Leasehold Real Estate Investment Trust
SET:B-WORK
|
TH |
Intrinsic Value
Is BMKDF undervalued or overvalued?
See the intrinsic value estimate for BioMark Diagnostics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BMKDF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with BMKDF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What BioMark Diagnostics Does
BioMark Diagnostics Inc. is a molecular diagnostics company that develops blood- and urine-based tests for cancer detection and monitoring. Its products are meant to help find signs of disease earlier, support diagnosis, and track whether cancer is returning or responding to treatment. The company’s work centers on biomarker testing, where it looks for biological signals linked to specific cancers rather than selling drugs or hospital equipment.
- Headquarters
- Canada CA
- IPO date
- Nov 3, 2014
Revenue & Expenses Breakdown
BioMark Diagnostics Inc
Earnings Waterfall
BioMark Diagnostics Inc
The intrinsic value for BioMark Diagnostics Inc (BMKDF) under the Base Case is hidden USD.
Compared with the current market price of 0.3769 USD, the stock appears hidden.